Guochun Li is the founder of Brise Pharma. Brise Pharma has raised $48M in total funding. Latest round: Series A. Based in Shanghai, China.
Guochun Li is the CEO of Brise Pharma, a clinical-stage biopharmaceutical company based in Shanghai, China. Founded in 2021, Brise Pharma specializes in developing innovative small-molecule drugs for severe chronic pain conditions, including migraine, neuropathic, and musculoskeletal pain. The company has advanced two molecules to the clinical stage in the US and China and has secured approximately $48 million in Pre-A, Pre-A+, and Series A financing rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library